Literature DB >> 12058043

Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis.

Laura L Atkinson1, Melanie A Fischer, Gary D Lopaschuk.   

Abstract

Leptin regulates fatty acid metabolism in liver, skeletal muscle, and pancreas by partitioning fatty acids into oxidation rather than triacylglycerol (TG) storage. Although leptin receptors are present in the heart, it is not known whether leptin also regulates cardiac fatty acid metabolism. To determine whether leptin directly regulates cardiac fatty acid metabolism, isolated working rat hearts were perfused with 0.8 mm [9,10-(3)H]palmitate and 5 mm [1-(14)C]glucose to measure palmitate and glucose oxidation rates. Leptin (60 ng/ml) significantly increased palmitate oxidation rates 60% above control hearts (p < 0.05) and decreased TG content by 33% (p < 0.05) over the 60-min perfusion period. In contrast, there was no difference in glucose oxidation rates between leptin-treated and control hearts. Although leptin did not affect cardiac work, oxygen consumption increased by 30% (p < 0.05) and cardiac efficiency was decreased by 42% (p < 0.05). AMP-activated protein kinase (AMPK) plays a major role in the regulation of cardiac fatty acid oxidation by inhibiting acetyl-CoA carboxylase (ACC) and reducing malonyl-CoA levels. Leptin has also been shown to increase fatty acid oxidation in skeletal muscle through the activation of AMPK. However, we demonstrate that leptin had no significant effect on AMPK activity, AMPK phosphorylation state, ACC activity, or malonyl-CoA levels. AMPK activity and its phosphorylation state were also unaffected after 5 and 10 min of perfusion in the presence of leptin. The addition of insulin (100 microunits/ml) to the perfusate reduced the ability of leptin to increase fatty acid oxidation and decrease cardiac TG content. These data demonstrate for the first time that leptin activates fatty acid oxidation and decreases TG content in the heart. We also show that the effects of leptin in the heart are independent of changes in the AMPK-ACC-malonyl-CoA axis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12058043     DOI: 10.1074/jbc.M203813200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts.

Authors:  Adrian Chabowski; Iman Momken; Susan L M Coort; Jorge Calles-Escandon; Narendra N Tandon; Jan F C Glatz; Joost J F P Luiken; Arend Bonen
Journal:  Mol Cell Biochem       Date:  2006-05-19       Impact factor: 3.396

Review 2.  Cardiovascular effects of leptin.

Authors:  Gary Sweeney
Journal:  Nat Rev Cardiol       Date:  2009-12-01       Impact factor: 32.419

3.  Obesity-induced changes in kidney mitochondria and endoplasmic reticulum in the presence or absence of leptin.

Authors:  Shankar Munusamy; Jussara M do Carmo; Jonathan P Hosler; John E Hall
Journal:  Am J Physiol Renal Physiol       Date:  2015-08-19

4.  Leptin augments the acute suppressive effects of insulin on hepatic very low-density lipoprotein production in rats.

Authors:  Wan Huang; Anantha Metlakunta; Nikolas Dedousis; Heidi K Ortmeyer; Maja Stefanovic-Racic; Robert M O'Doherty
Journal:  Endocrinology       Date:  2009-01-15       Impact factor: 4.736

5.  Leptin ameliorates insulin resistance and hepatic steatosis in Agpat2-/- lipodystrophic mice independent of hepatocyte leptin receptors.

Authors:  Víctor A Cortés; Kelly M Cautivo; Shunxing Rong; Abhimanyu Garg; Jay D Horton; Anil K Agarwal
Journal:  J Lipid Res       Date:  2013-11-30       Impact factor: 5.922

Review 6.  The ABC transporter structure and mechanism: perspectives on recent research.

Authors:  P M Jones; A M George
Journal:  Cell Mol Life Sci       Date:  2004-03       Impact factor: 9.261

7.  AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation.

Authors:  Haihong Zong; Jian Ming Ren; Lawrence H Young; Marc Pypaert; James Mu; Morris J Birnbaum; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-20       Impact factor: 11.205

8.  Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice.

Authors:  Young Lee; R Haris Naseem; Laurence Duplomb; Byung-Hyun Park; Daniel J Garry; James A Richardson; Jean E Schaffer; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-03       Impact factor: 11.205

9.  Protein-mediated Fatty Acid Uptake in the Heart.

Authors:  Adrian Chabowski; Jan Górski; Jan F C Glatz; Joost J F P Luiken; Arend Bonen
Journal:  Curr Cardiol Rev       Date:  2008-02

10.  Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase.

Authors:  John R Ussher; Timothy R Koves; Jagdip S Jaswal; Liyan Zhang; Olga Ilkayeva; Jason R B Dyck; Deborah M Muoio; Gary D Lopaschuk
Journal:  Diabetes       Date:  2009-05-28       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.